✦ LIBER ✦

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

✍ Scribed by Grimwade, D; Lo Coco, F

Book ID: 110055278
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 290 KB
Volume: 16
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2402721

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New approaches for the detection of mini

New approaches for the detection of minimal residual disease in acute myeloid leukemia

✍ Anna van Rhenen; Bijan Moshaver; Gert J. Ossenkoppele; Gerrit Jan Schuurhuis 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 855 KB

Expression patterns of WT1 and PRAME in

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease

✍ YaZhen Qin; HongHu Zhu; Bin Jiang; JinLan Li; XiJing Lu; LingDi Li; GuoRui Ruan; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Both WT1 and PRAME are highly expressed in acute myeloid leukemia (AML) patients. To assess the efficacy of their simultaneous detection for the purpose of monitoring minimal residual disease (MRD), we used real-time quantitative RT-PCR to quantify both WT1 and PRAME transcript levels in the bone ma

No role for CXCL12–G801A polymorphism in

No role for CXCL12–G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia

✍ Ponziani, V; Mannelli, F; Bartalucci, N; Gianfaldoni, G; Leoni, F; Antonioli, E; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Functional characterization of minimal r

Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia

✍ van der Pol, M A; Pater, J M; Feller, N; Westra, A H; van Stijn, A; Ossenkoppele 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB

Tandem duplication of the FLT3 gene in a

Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease

✍ Nakao, M; Janssen, J W G; Erz, D; Seriu, T; Bartram, C R 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

Expression of the hMICL in acute myeloid

Expression of the hMICL in acute myeloid leukemia—a highly reliable disease marker at diagnosis and during follow-up

✍ Hanne Ø. Larsen; Anne S. Roug; Tom Just; Gordon D. Brown; Peter Hokland 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB